About Us

Allied Research International, a member of Cetero Research, has been in operation since 1989. As part of a family with 3 other clinical and bioanalytical companies (PRACS Institute, Gateway Medical Research, and Ba Research), we are one of the world’s leading providers of early stage, bioanalytical and niche late stage clinical research services to the life sciences industry.

Responsive. Innovative. Scientific Excellence.

In four words, this is ARI’s focus and promise. For clients. For vendors. For study participants. For the community.

We believe that responsiveness takes center stage. Our 18 years in conducting clinical trials and collaboration with stakeholders has revealed a simple truth – the only constant in the world is change. To flow with the winds of change we must adapt and be responsive. We are constantly attuned to the world around us, anticipate changes, and take action. From conducting clinical trials, to listening attentively to our sponsors, vendors, study participants and the community, we are always ready for change and respond quickly. Responsiveness is in the cornerstone of everything we do, and our focus continues to win accolades in the life science and business communities.

Innovation is second nature at Allied Research International. Collaborating with members of the Cetero Research family and network in the life science industry, we constantly seek new and efficient methods in conducting clinical trials. ARI is the leader in respiratory and immunology clinical research, and invests in research and development of new clinical models and the Environmental Exposure Chamber technology.

Conducting clinical research requires scientific know-how. Conducting world-class clinical research requires an unwavering focus on delivering the best scientific know-how. By maintaining a culture of responsiveness and innovation, and attracting the best scientific staff, we apply scientific expertise and strive for excellence into every aspect of the research project.

The drug development process is complex. Let ARI provide clarity and guidance for your drug development plan.

Responsive. Innovative. Scientific Excellence.